IQVIA Holdings announced upward revisions to its 2026 outlook and bookings forecast. The company highlighted growth drivers such as AI-enabled clinical data delivery, while the launch of IQVIA.ai through its partnership with NVIDIA is also viewed as significant.
IQVIA Holdings announced upward revisions to its 2026 outlook and bookings forecast. The revisions were driven by recent results exceeding market expectations and continued solid demand for AI-enabled, data-driven solutions.
The company presented a long-term forecast calling for revenue of $20.4 billion and earnings of $2.0 billion by 2029. Achieving this would require annual revenue growth of approximately 6.3% and an increase of approximately $600 million from current earnings of about $1.4 billion.
Among its AI initiatives, the launch of IQVIA.ai through the partnership with NVIDIA has drawn attention. The company indicated that the delivery of AI-enabled clinical and real-world data is expected to support sustained demand and resilient margins.
Another analyst is more cautious on the 2029 outlook, estimating revenue of approximately $19.4 billion and earnings of approximately $1.8 billion. In terms of market valuation, fair value is estimated at $275.17, implying approximately 5% upside from the current share price.